We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The merger “has the potential to transform the way healthcare is delivered to those suffering from cardiovascular or peripheral disease,” says Corindus CEO Mark Toland. Read More